Miller F R, Heppner G H
J Natl Cancer Inst. 1979 Dec;63(6):1457-63.
Five subpopulations (66, 67, 68H, 168, and 4.10LM) obtained from a single BALB/cfC3H mammary adenocarcinoma were used to assess intratumor immunologic heterogeneity. BALB/c and BALB/cfC3H mice were immunized with each of the subpopulations, and lymph node cells (LNC) from immunized animals were tested for cell-mediated immunity (CMI) to each subpopulation in vitro by chromium release and microcytotoxicity tests and in vivo by Winn assays. The immunogenic character of the subpopulations differed markedly. The pattern of cross-reactivity indicated that at least two determinants were involved, one of which was probably a viral antigen. The viral antigen was expressed on 4 subpopulations (66, 68H, 168, and 4.10LM). The other determinant was immunogenic in both BALB/c and BALB/cfC3H mice and was expressed on 4 subpopulations (66, 67, 168, and 4.10lm). Thus 1 subpopulation (68H) expressed only the viral antigen, 1 (67) expressed only the other antigen, and 3 (66, 168, and 4.10LM) expressed both. Expression of the determinants showed qualitative and quantitative variations. Quantitative differences were noted by the relative effectiveness of the subpopulations to induce CMI and by the relative sensitivities to LNC-mediated killing. Qualitative differences were indicated by the occurrence of unidirectional cross-reactivities between some pairs of subpopulations; a determinant could be expressed so that the subpopulation could induce cytotoxic cells but not be sensitive to them or vice versa.
从一只BALB/cfC3H乳腺腺癌中获得的五个亚群(66、67、68H、168和4.10LM)用于评估肿瘤内免疫异质性。用每个亚群免疫BALB/c和BALB/cfC3H小鼠,并通过铬释放和微细胞毒性试验在体外以及通过Winn试验在体内检测免疫动物的淋巴结细胞(LNC)对每个亚群的细胞介导免疫(CMI)。亚群的免疫原性特征有显著差异。交叉反应模式表明至少涉及两个决定簇,其中一个可能是病毒抗原。病毒抗原在4个亚群(66、68H、168和4.10LM)上表达。另一个决定簇在BALB/c和BALB/cfC3H小鼠中均具有免疫原性,并在4个亚群(66、67、168和4.10lm)上表达。因此,1个亚群(68H)仅表达病毒抗原,1个(67)仅表达另一种抗原,3个(66、168和4.10LM)表达两种抗原。决定簇的表达显示出质和量的变化。通过亚群诱导CMI的相对有效性以及对LNC介导杀伤的相对敏感性注意到量的差异。质的差异通过一些亚群对之间单向交叉反应的出现来表明;一个决定簇可以以这样的方式表达,即亚群可以诱导细胞毒性细胞但对它们不敏感,反之亦然。